Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
HU-LOWE, Dana D, ZOU, Helen Y, MCTIGUE, Michele A, MURRAY, Brion W, KANIA, Robert S, O'CONNOR, Patrick, SHALINSKY, David R, BENDER, Steve L, GRAZZINI, Maren L, HALLIN, Max E, WICKMAN, Grant R, AMUNDSON, Karin, CHEN, Jeffrey H, REWOLINSKI, David A, YAMAZAKI, Shinji, WU, Ellen Y
Published in Clinical cancer research (15.11.2008)
Published in Clinical cancer research (15.11.2008)
Get full text
Journal Article